-
Je něco špatně v tomto záznamu ?
The effects of IFITM1 and IFITM3 gene deletion on IFNγ stimulated protein synthesis
M. Gómez-Herranz, M. Nekulova, J. Faktor, L. Hernychova, S. Kote, EH. Sinclair, R. Nenutil, B. Vojtesek, KL. Ball, TR. Hupp,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
BB/C511599/1
Biotechnology and Biological Sciences Research Council - United Kingdom
- MeSH
- buněčné linie MeSH
- diferenciační antigeny fyziologie MeSH
- histokompatibilita - antigeny třídy I metabolismus MeSH
- lidé MeSH
- membránové proteiny fyziologie MeSH
- nádory děložního čípku metabolismus MeSH
- proteiny vázající RNA fyziologie MeSH
- proteosyntéza fyziologie MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Interferon-induced transmembrane proteins IFITM1 and IFITM3 (IFITM1/3) play a role in both RNA viral restriction and in human cancer progression. Using immunohistochemical staining of FFPE tissue, we identified subgroups of cervical cancer patients where IFITM1/3 protein expression is inversely related to metastasis. Guide RNA-CAS9 methods were used to develop an isogenic IFITM1/IFITM3 double null cervical cancer model in order to define dominant pathways triggered by presence or absence of IFITM1/3 signalling. A pulse SILAC methodology identified IRF1, HLA-B, and ISG15 as the most dominating IFNγ inducible proteins whose synthesis was attenuated in the IFITM1/IFITM3 double-null cells. Conversely, SWATH-IP mass spectrometry of ectopically expressed SBP-tagged IFITM1 identified ISG15 and HLA-B as dominant co-associated proteins. ISG15ylation was attenuated in IFNγ treated IFITM1/IFITM3 double-null cells. Proximity ligation assays indicated that HLA-B can interact with IFITM1/3 proteins in parental SiHa cells. Cell surface expression of HLA-B was attenuated in IFNγ treated IFITM1/IFITM3 double-null cells. SWATH-MS proteomic screens in cells treated with IFITM1-targeted siRNA cells resulted in the attenuation of an interferon regulated protein subpopulation including MHC Class I molecules as well as IFITM3, STAT1, B2M, and ISG15. These data have implications for the function of IFITM1/3 in mediating IFNγ stimulated protein synthesis including ISG15ylation and MHC Class I production in cancer cells. The data together suggest that pro-metastatic growth associated with IFITM1/3 negative cervical cancers relates to attenuated expression of MHC Class I molecules that would support tumor immune escape.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025728
- 003
- CZ-PrNML
- 005
- 20201222154049.0
- 007
- ta
- 008
- 201125s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.cellsig.2019.03.024 $2 doi
- 035 __
- $a (PubMed)30951861
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Gómez-Herranz, Maria $u University of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh EH4 2XR, United Kingdom.
- 245 14
- $a The effects of IFITM1 and IFITM3 gene deletion on IFNγ stimulated protein synthesis / $c M. Gómez-Herranz, M. Nekulova, J. Faktor, L. Hernychova, S. Kote, EH. Sinclair, R. Nenutil, B. Vojtesek, KL. Ball, TR. Hupp,
- 520 9_
- $a Interferon-induced transmembrane proteins IFITM1 and IFITM3 (IFITM1/3) play a role in both RNA viral restriction and in human cancer progression. Using immunohistochemical staining of FFPE tissue, we identified subgroups of cervical cancer patients where IFITM1/3 protein expression is inversely related to metastasis. Guide RNA-CAS9 methods were used to develop an isogenic IFITM1/IFITM3 double null cervical cancer model in order to define dominant pathways triggered by presence or absence of IFITM1/3 signalling. A pulse SILAC methodology identified IRF1, HLA-B, and ISG15 as the most dominating IFNγ inducible proteins whose synthesis was attenuated in the IFITM1/IFITM3 double-null cells. Conversely, SWATH-IP mass spectrometry of ectopically expressed SBP-tagged IFITM1 identified ISG15 and HLA-B as dominant co-associated proteins. ISG15ylation was attenuated in IFNγ treated IFITM1/IFITM3 double-null cells. Proximity ligation assays indicated that HLA-B can interact with IFITM1/3 proteins in parental SiHa cells. Cell surface expression of HLA-B was attenuated in IFNγ treated IFITM1/IFITM3 double-null cells. SWATH-MS proteomic screens in cells treated with IFITM1-targeted siRNA cells resulted in the attenuation of an interferon regulated protein subpopulation including MHC Class I molecules as well as IFITM3, STAT1, B2M, and ISG15. These data have implications for the function of IFITM1/3 in mediating IFNγ stimulated protein synthesis including ISG15ylation and MHC Class I production in cancer cells. The data together suggest that pro-metastatic growth associated with IFITM1/3 negative cervical cancers relates to attenuated expression of MHC Class I molecules that would support tumor immune escape.
- 650 _2
- $a diferenciační antigeny $x fyziologie $7 D000943
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a histokompatibilita - antigeny třídy I $x metabolismus $7 D015395
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a membránové proteiny $x fyziologie $7 D008565
- 650 _2
- $a proteosyntéza $x fyziologie $7 D014176
- 650 _2
- $a proteiny vázající RNA $x fyziologie $7 D016601
- 650 _2
- $a nádory děložního čípku $x metabolismus $7 D002583
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Nekulova, Marta $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic.
- 700 1_
- $a Faktor, Jakub $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic.
- 700 1_
- $a Hernychova, Lenka $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic.
- 700 1_
- $a Kote, Sachin $u University of Gdansk, International Centre for Cancer Vaccine Science, Department of Chemistry, Gdansk, Poland.
- 700 1_
- $a Sinclair, Elizabeth H $u University of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh EH4 2XR, United Kingdom.
- 700 1_
- $a Nenutil, Rudolf $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic.
- 700 1_
- $a Vojtesek, Borivoj $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic. Electronic address: vojtesek@mou.cz.
- 700 1_
- $a Ball, Kathryn L $u University of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh EH4 2XR, United Kingdom; Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic. Electronic address: kathryn.ball@ed.ac.uk.
- 700 1_
- $a Hupp, Ted R $u University of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh EH4 2XR, United Kingdom; Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic; University of Gdansk, International Centre for Cancer Vaccine Science, Department of Chemistry, Gdansk, Poland. Electronic address: ted.hupp@ed.ac.uk.
- 773 0_
- $w MED00006628 $t Cellular signalling $x 1873-3913 $g Roč. 60, č. - (2019), s. 39-56
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30951861 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222154045 $b ABA008
- 999 __
- $a ok $b bmc $g 1599873 $s 1116414
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 60 $c - $d 39-56 $e 20190402 $i 1873-3913 $m Cellular signalling $n Cell Signal $x MED00006628
- GRA __
- $a BB/C511599/1 $p Biotechnology and Biological Sciences Research Council $2 United Kingdom
- LZP __
- $a Pubmed-20201125
